A Study of the RevLite Q-Switched Nd:YAG Laser System With Smart Infinite (SI) Handpiece for the Treatment of Refractory Mixed Type Melasma

NCT01335581 NA COMPLETED Results posted

The purpose of this study is to evaluate the RevLite laser in the treatment of refractory mixed type melasma.

Details

Lead sponsor	ConBio, a Cynosure Company
Phase	NA
Status	COMPLETED
Enrolment	18
Start date	2011-04
Completion	2012-03

Conditions

• Refractory Mixed Type Melasma

Interventions

• Q-Switched Nd:YAG Laser (RevLite)
• Retin-A and microdermabrasion

Primary outcomes

• Melasma Area Severity Assessment (MASI) Score Change From Baseline to Follow Up — 3 Months
  The severity of the melasma is assessed based on a photographic scale. The scale ranges from 0 to 48, with 48 being the most severe. A decrease in the MASI score from the baseline to the follow up corresponds with decreasing severity.

Countries

United States